Guru Sonpavde: Penile Cancer Update at MaTOS2026
Guru P. Sonpavde/adventhealthcancerinstitute.com

Guru Sonpavde: Penile Cancer Update at MaTOS2026

Guru Sonpavde, GU Oncology and Phase I Clinical Trials Director, Chair of Bladder Cancer Research at AdventHealth Central Florida, Professor of Medicine at the University of Central Florida, and at Loma Linda University Health, shared a post on LinkedIn.

“Penile Cancer update at MaTOS2026

Pleased to attend and discuss from Adventhealth Cancer Institute, AdventHealth Central Florida – Global collaboration is critically important to accelerate advances.

Thanks to organizers.”

Guru Sonpavde: Penile Cancer Update at MaTOS2026

Other articles featuring Guru Sonpavde on OncoDaily.